Abstract

The common cold remains one of the most prevalent reasons for medical consultations worldwide. Nasal congestion is among its most troublesome symptoms, often leading to significant discomfort and impaired quality of life. Nasal decongestants are widely used for symptomatic relief, yet their misuse or overuse may result in complications such as rebound congestion, hypertension, and drug interactions. This lecture will provide an overview of the common cold, its pathophysiology, and symptomatic management with a special focus on nasal decongestants. Attendees will gain insights into the pharmacology, clinical applications, contraindications, and safe prescribing practices of these agents, empowering them to optimize patient outcomes while minimizing risks. 

Learning Objectives

• Describe the epidemiology and natural course of the common cold. 
• Explain the mechanism of action of nasal decongestants and their role in symptom relief. 
• Identify the potential risks and complications of nasal decongestant misuse. 
• Apply safe prescribing practices in different patient populations, including children, pregnant women, and patients with comorbidities. 
• Counsel patients effectively on appropriate use, duration, and alternatives to nasal decongestants.

Supported by